Gender Effects on Rat Metabolism of AMG 900, an Orally Available Small Molecule Aurora Kinase Inhibitor

Publisher： Bentham Science Publishers

E-ISSN： 1874-0758|5|4|290-297

ISSN： 1872-3128

Source： Drug Metabolism Letters, Vol.5, Iss.4, 2011-12, pp. : 290-297

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pazopanib, a potent orally administered small-molecule multitargeted tyrosine kinase inhibitor for renal cell carcinoma

By Sonpavde Guru   Hutson Thomas E   Sternberg Cora N  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 2, 2008-02 ,pp. : 253-261

Informa Healthcare

Access to resources Recommend Favorite

Danusertib, an aurora kinase inhibitor

By Meulenbeld Hielke J   Mathijssen Ron HJ   Verweij Jaap   de Wit Ronald   de Jonge Maja JA  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 3, 2012-03 ,pp. : 383-393

Informa Healthcare

Access to resources Recommend Favorite

Small Molecule Aurora Kinases Inhibitors

By  

Current Medicinal Chemistry, Vol. 16, Iss. 16, 2009-06 ,pp. : 1949-1963

Bentham Science Publishers

Access to resources Recommend Favorite

Preclinical Drug Metabolism and Pharmacokinetics, and Prediction of Human Pharmacokinetics and Efficacious Dose of the Investigational Aurora A Kinase Inhibitor Alisertib (MLN8237)

By  

Drug Metabolism Letters, Vol. 7, Iss. 2, 2014-05 ,pp. : 96-104

Bentham Science Publishers

Access to resources Recommend Favorite

Metabolism and Disposition of Pacritinib (SB1518), an Orally Active Janus Kinase 2 Inhibitor in Preclinical Species and Humans

By  

Drug Metabolism Letters, Vol. 9, Iss. 1, 2015-04 ,pp. : 28-47

Bentham Science Publishers

Access to resources Recommend Favorite